» Articles » PMID: 28476172

ANCA-associated Vasculitis in Childhood: Recent Advances

Abstract

Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides are rare systemic diseases that usually occur in adulthood. They comprise granulomatosis with polyangiitis (GPA, Wegener's), microscopic polyangiitis (MPA) and eosinophilic granulomatosis with polyangiitis (EGPA, Churg-Strauss syndrome). Their clinical presentation is often heterogeneous, with frequent involvement of the respiratory tract, the kidney, the skin and the joints. ANCA-associated vasculitis is rare in childhood but North-American and European cohort studies performed during the last decade have clarified their phenotype, patterns of renal involvement and their prognostic implications, and outcome. Herein, we review the main clinical and therapeutic aspects of childhood-onset ANCA-associated vasculitis, and provide preliminary data on demographic characteristics and organ manifestations of an Italian multicentre cohort.

Citing Articles

In-Depth Analysis of Disease Manifestations in Antineutrophil Cytoplasmic Antibody-Associated Vasculitides Identifies Distinct Clinical Phenotypes.

Lindberg H, Knight A, Hellbacher E, Norling O, Berglin E, Stegmayr B ACR Open Rheumatol. 2025; 7(3):e70009.

PMID: 40033657 PMC: 11876290. DOI: 10.1002/acr2.70009.


Childhood-Onset ANCA-Associated Vasculitis: From Genetic Studies to Advances in Pathogenesis, Classification and Novel Therapeutic Approaches.

Yeo L, Naheed A, Richards C, Ciurtin C Int J Mol Sci. 2025; 25(24.

PMID: 39769465 PMC: 11676361. DOI: 10.3390/ijms252413704.


Vasculitis in Children.

Bayindir Y, Basaran O, Bilginer Y, Ozen S Turk Arch Pediatr. 2024; 59(6):517-526.

PMID: 39540696 PMC: 11562156. DOI: 10.5152/TurkArchPediatr.2024.24181.


[Clinical characteristics of children with anti-neutrophil cytoplasmic antibody-associated vasculitis].

Liu J, Li Y, Shuai L, Cao Y, Li X, Wang Y Zhongguo Dang Dai Er Ke Za Zhi. 2024; 26(8):823-828.

PMID: 39148386 PMC: 11334541. DOI: 10.7499/j.issn.1008-8830.2401074.


Thrombosis in vasculitis: An updated review of etiology, pathophysiology, and treatment.

Zhu K, Lv F, Hou X, Wang F, Pang L, Zhong M Heliyon. 2024; 10(12):e30615.

PMID: 38975109 PMC: 11225688. DOI: 10.1016/j.heliyon.2024.e30615.


References
1.
Lanham J, Elkon K, Pusey C, Hughes G . Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine (Baltimore). 1984; 63(2):65-81. DOI: 10.1097/00005792-198403000-00001. View

2.
Guillevin L, Pagnoux C, Karras A, Khouatra C, Aumaitre O, Cohen P . Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis. N Engl J Med. 2014; 371(19):1771-80. DOI: 10.1056/NEJMoa1404231. View

3.
Arulkumaran N, Jawad S, Smith S, Harper L, Brogan P, Pusey C . Long- term outcome of paediatric patients with ANCA vasculitis. Pediatr Rheumatol Online J. 2011; 9:12. PMC: 3150312. DOI: 10.1186/1546-0096-9-12. View

4.
Ozen S, Pistorio A, Iusan S, Bakkaloglu A, Herlin T, Brik R . EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis. 2010; 69(5):798-806. DOI: 10.1136/ard.2009.116657. View

5.
Akikusa J, Schneider R, Harvey E, Hebert D, Thorner P, Laxer R . Clinical features and outcome of pediatric Wegener's granulomatosis. Arthritis Rheum. 2007; 57(5):837-44. DOI: 10.1002/art.22774. View